Silverarc Capital Management’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.34M Buy
+560,651
New +$3.39M 0.34% 49
2025
Q4
Sell
-720,452
Closed -$3.12M 98
2025
Q3
$3.12M Buy
+720,452
New +$1.3M 0.42% 55
2024
Q3
Sell
-328,504
Closed -$1.15M 83
2024
Q2
$1.15M Hold
328,504
0.27% 55
2024
Q1
$844K Sell
328,504
-134,493
-29% -$477K 0.23% 61
2023
Q4
$2.16M Buy
462,997
+58,957
+15% +$295K 0.64% 46
2023
Q3
$2.67M Buy
404,040
+244,040
+153% +$1.63M 0.81% 41
2023
Q2
$1.31M Buy
+160,000
New +$1.29M 0.41% 53

Other funds holding ZURA

Silverarc Capital Management's ZURA Position: Q1 2026 in Review

Silverarc Capital Management opened a new position in Zura Bio (ZURA) in Q1 2026: 560,651 shares worth $3.34M. The stake represents 0.34% of the portfolio and ranks #49 among its holdings. This is a return to the name: Silverarc Capital Management previously reported a position in ZURA as recently as Q3 2025.

Silverarc Capital Management first reported a position in ZURA in Q2 2023 and has held it in 7 quarters since. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Silverarc Capital Management held 560,651 shares of Zura Bio worth $3.34M as of Q1 2026.
  • Zura Bio was a new Silverarc Capital Management position in Q1 2026.
  • Zura Bio made up 0.34% of Silverarc Capital Management's portfolio in Q1 2026, its #49 holding.
  • Silverarc Capital Management first reported a position in Zura Bio in Q2 2023 and has held it in 7 quarters since.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Silverarc Capital Management's 13F filing for Q1 2026, filed 14 May 2026.